• 1 Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan
  • 2 St. Vincent's Pathology, St. Vincent's Health Network, Sydney, and Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), Sydney, Australia
  • 3 Department of Hematology and BMT, Dhaka Medical College and Hospital, Dhaka, Bangladesh
  • 4 Department of Haematology, Christian Medical College Hospital, Vellore, India
  • 5 Division of Hematology-Oncology, Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
  • 6 Stem Cell Transplantation Department, Blood Transfusion and Hematology Hospital, Ho Chi Minh, Vietnam
  • 7 St Luke's Medical Center Quezon City, IM Hematology/Blood and Marrow Transplant, Quezon, Philippines
  • 8 Department of Clinical Haematology, North Okkalapa General Hospital, Yangon, Myanmar
  • 9 Department of Oncology, National Cancer Institute, Maharagama, Sri Lanka
  • 10 Department of Hematology, Peking University Institute of Hematology, Beijing, China
  • 11 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • 12 Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • 13 Department of Hematology, Hospital Ampang, Ampang Selangor, Malaysia
  • 14 Department of Haematology, Singapore General Hospital, Singapore
  • 15 Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
  • 16 Department of Clinical Haematology, National Institute of Blood Disease and Bone Marrow Transplantation, Karachi, Pakistan
  • 17 Department of Medicine, Queen Mary Hospital, Hong Kong
  • 18 Civil Service Hospital, Clinical Hematology and Bone Marrow Transplant Unit, Kathmandu, Nepal
  • 19 Bone and Marrow transplantation team, Hematology Department, National First Central Hospital of Mongolia, Ulaanbaatar, Mongolia
  • 20 Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
  • 21 Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Nagoya, Japan
Blood Cell Ther, 2021 May 25;4(2):20-28.
PMID: 36712901 DOI: 10.31547/bct-2020-013


This report describes the results of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT) Activity Survey 2016, focusing on the trends of haploidentical and cord blood (CB) transplants in the Asia-Pacific region. Mongolia and Nepal submitted their first activity data in this survey, and the number of countries/regions participating in the activity survey grew to 20. The annual number of transplants exceeded 20,000 for the first time in 2016, and the total number of centers increased to 686. About 87.9% of all hematopoietic stem cell transplantations (HSCTs) were performed in China, Japan, Korea, India, and Australia with China performing the highest number. Beginning with the 2016 survey, APBMT modified the survey forms and initiated the collection of the exact number of haploidentical transplants. The total number of such transplants was 3,871, and 66.0% of those were performed in China. Meanwhile, cord blood transplants in this region remained high (1,612), and 81.8% of them (1,319) were performed in Japan. The number of facilities and transplants, the ratio of haploidentical transplants to related transplants, the ratio of CB transplants to unrelated transplants, and proportions of haploidentical and CB transplants per capita significantly differed among countries/regions in the Asia-Pacific region. Data collection and analysis revealed the transition and diversity of transplants in this region. This report also shows a dramatic increase in haploidentical transplants as seen in other parts of the world, while revealing uniquely that the activity of cord blood transplant remains high in this region.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.